Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4

PLoS One. 2014 Jul 1;9(7):e101457. doi: 10.1371/journal.pone.0101457. eCollection 2014.

Abstract

Background: The molecular mechanism between Helicobacter pylori (H. pylori) infection and gastric cancer remained largely unknown. In this study, we determined the role of miRNA in H. pylori induced gastric cancer.

Methods and results: We found that miR-204 was decreased in H. pylori positive tissues by qRT-PCR. Knockdown of miR-204 enhanced the invasion and proliferation ability of gastric cancer cells in vitro. Luciferase assay revealed that SOX4 was target gene of miR-204, which was found up-regulated in H. pylori positive tissues. Down-regulation of miR-204 and over-expression of SOX4 promoted epithelial-mesenchymal transition process.

Conclusion: Taken together, our findings demonstrated that miR-204 may act as a tumor suppressor in H. pylori induced gastric cancer by targeting SOX4.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Adult
  • Aged
  • Cell Proliferation / genetics*
  • Epithelial-Mesenchymal Transition
  • Female
  • Genes, Tumor Suppressor*
  • Helicobacter Infections* / genetics
  • Helicobacter Infections* / metabolism
  • Helicobacter Infections* / pathology
  • Helicobacter pylori*
  • Humans
  • Male
  • MicroRNAs* / biosynthesis
  • MicroRNAs* / genetics
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Proteins* / genetics
  • Neoplasm Proteins* / metabolism
  • RNA, Neoplasm* / biosynthesis
  • RNA, Neoplasm* / genetics
  • SOXC Transcription Factors* / genetics
  • SOXC Transcription Factors* / metabolism
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / metabolism
  • Stomach Neoplasms* / microbiology
  • Stomach Neoplasms* / pathology

Substances

  • MIRN204 microRNA, human
  • MicroRNAs
  • Neoplasm Proteins
  • RNA, Neoplasm
  • SOX4 protein, human
  • SOXC Transcription Factors

Grants and funding

Guoxin Zhang was funded by National Natural Science Foundation of China (No. 81270476) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.